| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$318 |
PIA Presentation - Proposed Enhancements to Portfolio
|
21 Aug 2025 8:34AM |
$1.220 |
$1.233 |
risen by
1.02%
|
|
PIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Proposal to increase PIA portfolio allocation to the Pengana High Conviction Equities Fund to 100%
- Rationale includes historical outperformance and simplification of investment process
- Shareholder approval is required for the proposed changes
- Implementation plan outlines a transition period and ongoing communication with shareholders
- Risk management, governance, and transparency remain priorities under the proposed structure
- No change to the PIA listed investment company structure or capital management policies
- Expected benefits include improved performance consistency and alignment of interests
- Anticipated impact on fees and performance metrics is discussed
- Current portfolio, investment strategies, and historical returns are reviewed
- Proposal aims to deliver long-term value for PIA shareholders
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,048 |
Preliminary Final Report
|
21 Aug 2025 8:33AM |
$6.930 |
$7.630 |
risen by
10.10%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities for the year ended 30 June 2025 was $10,481.5 million, down from $10,979.5 million in 2024.
- Total revenue including joint ventures and other income was $10,885.7 million, a 9.0% decrease from the previous year.
- Earnings before interest and tax (EBIT) increased by 56.9% to $283.2 million.
- Profit from ordinary activities after tax attributable to members of the parent entity rose by 97.8% to $136.7 million.
- Diluted earnings per share increased to 20.4 cents from 10.3 cents, marking a 98.1% improvement.
- Net tangible asset backing per ordinary share rose by 31.5% to 38.0 cents.
- Final dividend for 2025 was 14.1 cents per share, fully franked, with a record date of 04/09/2025 and payable on 02/10/2025.
- The Dividend Reinvestment Plan remains suspended.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,048 |
Preliminary Final Report
|
21 Aug 2025 8:33AM |
$6.930 |
$7.630 |
risen by
10.10%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities dropped by 4.7% to $10,531.5 million.
- EBIT increased by 56.9% to $283.2 million.
- Profit from ordinary activities after tax rose by 97.8% to $136.7 million.
- Dividend per share increased to 14.1 cents, fully franked.
- Dividend Reinvestment Plan remains suspended.
- Loss of control over some entities.
- Details about associates and joint ventures provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$523 |
2025 Appendix 4E and Annual Report
|
21 Aug 2025 8:33AM |
$29.610 |
$19.530 |
fallen by
34.04%
|
|
EQT - Price-sensitive ASX Announcement
Full Release
Key Points
- Comprehensive financial statements for the year ended 30 June 2025 are provided.
- Directors’ reports cover governance, strategy, and company objectives.
- Remuneration disclosures detail executive and board compensation.
- Corporate governance framework and compliance are discussed.
- Risk management, audit outcomes, and sustainability commitments are highlighted.
- Key financial results including revenue, profit, EPS, and dividends are disclosed.
- Significant operational and financial position changes are noted.
- Future outlook and challenges are discussed in detail.
- Commitment to responsible investment and stakeholder value is emphasized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sipa Resources Limited (SRI) ORDINARY FULLY PAID |
Materials |
- |
Completion of Heritage Survey at Crown Gold Project
|
21 Aug 2025 8:32AM |
$0.016 |
$0.016 |
fallen by
0%
|
|
SRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Sipa Resources Limited completed a heritage survey at the Crown Gold Project in Western Australia.
- The survey was conducted with the participation of Traditional Owners and Terra Rosa Consulting.
- The Crown Project is prospective for gold and base metals and is located near significant regional discoveries.
- Completion of the heritage survey allows Sipa to move forward with initial drilling plans.
- Drilling is expected to commence in the March 2024 quarter, pending final approvals.
- Sipa remains committed to working with Traditional Owners and regulatory bodies.
- The company is preparing for further exploration and potential resource discovery at the Crown Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ridley Corporation Limited (RIC) ORDINARY FULLY PAID |
Consumer Staple |
$1,023 |
FY25 Full Year Results Investor Presentation
|
21 Aug 2025 8:32AM |
$2.910 |
$2.730 |
fallen by
6.19%
|
|
RIC - Price-sensitive ASX Announcement
Full Release
Key Points
- Reviewed FY25 full year financial results including revenue and EBITDA performance.
- Outlined operational highlights and achievements across business segments.
- Presented updates on significant capital projects and infrastructure investments.
- Discussed market conditions and their impact on Ridley’s business.
- Detailed progress in sustainability initiatives and innovation projects.
- Provided outlook and guidance for the upcoming financial year.
- Summarized dividends, shareholder returns, and capital management strategies.
- Emphasized focus on operational improvement and customer engagement.
- Highlighted strategic priorities including new product development and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$72 |
PIA Proposed Enhancements to Portfolio and Dividends
|
21 Aug 2025 8:32AM |
$0.795 |
$0.735 |
fallen by
7.55%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- PCG announced enhancements to PIA portfolio and dividend policy.
- Introduction of a new international ethical investment strategy.
- Focus on a concentrated portfolio of the best global ethical ideas.
- Aim to deliver stronger risk-adjusted returns.
- Management by an experienced investment team.
- Proposed dividend policy targets higher and more stable dividends.
- Rationale and expected benefits of changes are outlined.
- Shareholder approval is required for implementation.
- Implementation timeline is provided in the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$318 |
PIA Proposed Enhancements to Portfolio and Dividends
|
21 Aug 2025 8:32AM |
$1.220 |
$1.233 |
risen by
1.02%
|
|
PIA - Price-sensitive ASX Announcement
Full Release
Key Points
- PIA proposes a more concentrated, high-conviction global equities portfolio.
- Portfolio changes include fewer holdings, higher active share, and an emphasis on fundamental research.
- The Board intends to refine the investment process to enhance capital growth and risk-adjusted returns.
- An enhanced dividend policy is proposed, focusing on regular and sustainable distributions to shareholders.
- Dividend enhancements will be subject to profit reserves and prudent capital management.
- Shareholder feedback is being sought on the proposed changes.
- Board reaffirms its commitment to transparency, alignment with shareholder interests, and maintaining performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canterbury Resources Ltd (CBY) ORDINARY FULLY PAID |
Materials |
$10 |
Share Purchase Plan
|
21 Aug 2025 8:32AM |
$0.021 |
$0.035 |
risen by
66.67%
|
|
CBY - Price-sensitive ASX Announcement
Full Release
Key Points
- Canterbury Resources Ltd announced a Share Purchase Plan (SPP) to raise capital.
- The SPP offers existing eligible shareholders the opportunity to purchase additional shares at a fixed price without brokerage fees.
- The document details eligibility, application process, and offer period for the SPP.
- Funds raised will support the company's exploration and development projects, with emphasis on Papua New Guinea assets.
- The SPP describes key risks, tax implications, and participant responsibilities.
- Shareholders are advised to review the information carefully and consider personal financial circumstances before applying.
- The key dates and instructions for applying to the SPP are specified within the document.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ridley Corporation Limited (RIC) ORDINARY FULLY PAID |
Consumer Staple |
$1,023 |
Dividend/Distribution - RIC
|
21 Aug 2025 8:32AM |
$2.910 |
$2.730 |
fallen by
6.19%
|
|
| Redox Limited (RDX) ORDINARY FULLY PAID |
Industrials |
$1,728 |
Dividend/Distribution - RDX
|
21 Aug 2025 8:31AM |
$2.100 |
$3.290 |
risen by
56.67%
|
|
| Redox Limited (RDX) ORDINARY FULLY PAID |
Industrials |
$1,728 |
Redox 2025 Corporate Governance Statement
|
21 Aug 2025 8:31AM |
$2.100 |
$3.290 |
risen by
56.67%
|
|
| Redox Limited (RDX) ORDINARY FULLY PAID |
Industrials |
$1,728 |
Redox FY25 Results Presentation
|
21 Aug 2025 8:31AM |
$2.100 |
$3.290 |
risen by
56.67%
|
|
RDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Redox Limited reported robust revenue growth and improved financial performance for FY25.
- EBITDA and NPAT both experienced year-over-year increases, attributed to higher sales volumes and margin improvements.
- Geographic expansion and sector diversification contributed positively to the company’s results.
- Operational efficiencies were realized through supply chain optimization and process digitalization.
- Strategic investments were made in infrastructure and technology to support future growth.
- The company advanced its sustainability and ESG initiatives, including emissions reduction and responsible sourcing.
- Risk management practices were strengthened to address market volatility and supply chain disruptions.
- The outlook for FY26 remains positive, with ongoing investments in growth and innovation expected to drive continued success.
- Shareholder engagement and communication remain a priority, with a focus on transparency and long-term value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peter Warren Automotive Holdings Limited (PWR) ORDINARY FULLY PAID |
Consumer Discretionary |
$195 |
Dividend/Distribution - PWR
|
21 Aug 2025 8:31AM |
$1.860 |
$1.130 |
fallen by
39.25%
|
|
| Ridley Corporation Limited (RIC) ORDINARY FULLY PAID |
Consumer Staple |
$1,023 |
Preliminary Final Report
|
21 Aug 2025 8:30AM |
$2.910 |
$2.730 |
fallen by
6.19%
|
|
RIC - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory Net Profit After Tax for the year ended 30 June 2023 was $25.4 million, underlying Net Profit After Tax was $31.7 million.
- Underlying EBITDA increased by 6% to $81.0 million compared to the prior year.
- Final dividend of 3.0 cents per share was declared, making a total fully franked full-year dividend of 6.0 cents per share.
- Sales revenue for the year was $1,320.0 million, a 9% increase from the previous year.
- The Animal Nutrition segment delivered higher earnings due to operational improvements and cost recovery initiatives.
- The Ingredients segment saw EBITDA growth driven by new customer contracts and increased volumes in aquafeed.
- Completion and commissioning of the new Tasmanian extrusion plant contributed to aquafeed growth.
- No significant changes in the state of affairs other than those detailed in the report.
- After balance date, no matters or circumstances have arisen that would significantly affect the company's operations or financial results.
- The company continues to focus on growth opportunities, operational efficiency, and risk management for future performance.
- Details on share capital, remuneration of directors and key management personnel, and statutory disclosures are included.
- Auditor’s independence declaration and compliance with corporate governance practices are provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,574 |
Update - Notification of buy-back - VNT
|
21 Aug 2025 8:30AM |
$5.490 |
$5.570 |
risen by
1.46%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,590 |
Corporate Governance Statement 2025
|
21 Aug 2025 8:30AM |
$4.280 |
$4.400 |
risen by
2.80%
|
|
| Acumentis Group Limited (ACU) ORDINARY FULLY PAID |
Real Estate |
$19 |
Dividend/Distribution - ACU
|
21 Aug 2025 8:30AM |
$0.070 |
$0.084 |
risen by
20%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,590 |
Dividend/Distribution - MGH
|
21 Aug 2025 8:29AM |
$4.280 |
$4.400 |
risen by
2.80%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$5,290 |
Telix H1 2025 Results Presentation
|
21 Aug 2025 8:29AM |
$16.920 |
$15.600 |
fallen by
7.80%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix global revenue increased by 63% year-over-year in H1 2025.
- The company's gross margin reflects a change in the product mix and strategic investments.
- There is a significant investment in commercial infrastructure and R&D, focusing on strategic growth opportunities.
- Precision Medicine segment reported a 24% increase in EBITDA, with ongoing investments in commercial performance.
- Telix is advancing its pipeline in urologic and neurologic oncology, including several first-in-class therapies.
- The company achieved global regulatory approvals for various products, with Illuccix showing significant growth and market penetration.
- Telix's financial strategy aligns with growth opportunities, focusing on commercial infrastructure and therapeutic pipeline development.
- The company's FY 2025 guidance remains maintained, with expectations of continued growth through product and geographic expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$5,290 |
Telix H1 2025 Results Presentation
|
21 Aug 2025 8:29AM |
$16.920 |
$15.600 |
fallen by
7.80%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix's revenue increased by 63% YoY to $390.4 million in H1 2025.
- Illuccix® continues to be a key driver of revenue growth.
- Significant investment in R&D, with a 47% increase YoY.
- Expansion of global manufacturing operations, including integration of RLS.
- On track to meet FY 2025 revenue guidance of $770M - $800M.
- Advancements in clinical trials for oncology therapeutics.
- Continued investment in precision medicine and commercial infrastructure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$318 |
PIA Corporate Timetable
|
21 Aug 2025 8:29AM |
$1.220 |
$1.233 |
risen by
1.02%
|
|
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$711 |
FDA clearance of Salix Coronary Plaque module
|
21 Aug 2025 8:29AM |
$1.300 |
$4.450 |
risen by
242.31%
|
|
AYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Artrya Limited announced FDA 510(k) clearance for its Salix Coronary Plaque (SCP) module.
- The SCP module uses AI to detect and quantify coronary atherosclerotic plaque.
- FDA clearance enables commercialization of the SCP module in the United States.
- The technology provides clinicians with detailed plaque characterization to aid in coronary artery disease management.
- The FDA approval is a strategic milestone for Artrya, validating its technology and supporting U.S. market entry.
- Coronary artery disease is a major health issue and the SCP module addresses a significant clinical need.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Redox Limited (RDX) ORDINARY FULLY PAID |
Industrials |
$1,728 |
Redox FY25 Results Announcement
|
21 Aug 2025 8:29AM |
$2.100 |
$3.290 |
risen by
56.67%
|
|
RDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Redox Limited reported strong revenue growth and improved profitability for FY25.
- Expansion occurred in both domestic and international markets.
- The company’s performance was driven by effective supply chain management and strategic acquisitions.
- Redox maintained a diversified product portfolio focused on specialty chemical distribution.
- Management highlighted sustainability, customer relationships, and innovation as strategic priorities.
- Challenges included inflationary pressures and global supply disruptions.
- Redox implemented mitigation strategies to address operational challenges.
- The outlook for FY26 is positive with plans for further investment in technology, infrastructure, and talent.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$318 |
Appendix 4G 30 June 2025
|
21 Aug 2025 8:28AM |
$1.220 |
$1.233 |
risen by
1.02%
|
|
Call 1300 880 160
Start a chat
Schedule a call
